These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27343851)

  • 1. Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands.
    Párraga J; Andujar SA; Rojas S; Gutierrez LJ; El Aouad N; Sanz MJ; Enriz RD; Cabedo N; Cortes D
    Eur J Med Chem; 2016 Oct; 122():27-42. PubMed ID: 27343851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of hexahydrocyclopenta[ij]isoquinolines as a new class of dopaminergic agents.
    Párraga J; Galán A; Sanz MJ; Cabedo N; Cortes D
    Eur J Med Chem; 2015 Jan; 90():101-6. PubMed ID: 25461315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3,9- and 2,3,11-trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands.
    Párraga J; Cabedo N; Andujar S; Piqueras L; Moreno L; Galán A; Angelina E; Enriz RD; Ivorra MD; Sanz MJ; Cortes D
    Eur J Med Chem; 2013 Oct; 68():150-66. PubMed ID: 23974015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
    Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
    J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Teoh B; Criscione KR
    J Med Chem; 1999 Jun; 42(11):1982-90. PubMed ID: 10354406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular electrostatic potential of D1 and D2 dopamine agonists.
    Alkorta I; Villar HO
    J Med Chem; 1994 Jan; 37(1):210-3. PubMed ID: 7904647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Dihydroxy- and 3,4-methylenedioxy- phenanthrene-type alkaloids with high selectivity for D2 dopamine receptor.
    Moreno L; Cabedo N; Ivorra MD; Sanz MJ; Castel AL; Carmen Álvarez M; Cortes D
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4824-7. PubMed ID: 23886690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dopaminergic activity of a series of new 1-aryl tetrahydroisoquinolines and 2-substituted 1-aryl-3-tetrahydrobenzazepines.
    Lucena-Serrano C; Lucena-Serrano A; Rivera A; López-Romero JM; Valpuesta M; Díaz A
    Bioorg Chem; 2018 Oct; 80():480-491. PubMed ID: 29990896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D3 receptor ligands with antagonist properties.
    Hackling AE; Stark H
    Chembiochem; 2002 Oct; 3(10):946-61. PubMed ID: 12362359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
    Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
    Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
    J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives.
    El Aouad N; Berenguer I; Romero V; Marín P; Serrano A; Andujar S; Suvire F; Bermejo A; Ivorra MD; Enriz RD; Cabedo N; Cortes D
    Eur J Med Chem; 2009 Nov; 44(11):4616-21. PubMed ID: 19628309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationships.
    Teeter MM; Durand CJ
    Drug Des Discov; 1996 Apr; 13(3-4):49-62. PubMed ID: 8874043
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.